Gynaecological sarcoma
The names of the lead clinicians for the IRCI Gynaecological sarcoma group include:
Professor Jean-Yves Blay (EORTC)
Dr Helen Hatcher (UK)
Dr Martee Hensley (US)
Current active trial
A randomized phase II study evaluating the role of maintenance therapy with cabozantinib vs placebo in High Grade Uterine Sarcoma (HGUS) after stabilization or response to CT following surgery or in metastatic 1st-line treatment (International Rare Cancers Initiative study – IRCI 006)
